CDK4 and neoplasm: CDK4 and 6 inhibitors can block CDK4 and 6 kinase activity, which reduces the phosphorylation level of the Rb protein, inhibiting transcription factors to inhibit cancer cell division and proliferation, restore cell cycle control, block tumor cell proliferation, and inhibit breast cancer cell growth (Rubin et al. 2020).